The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.

Lu, Guangxian; Li, Jianhua; Ding, Leyun; Wang, Chenping; Tang, Lian; Liu, Xin; Xu, Jinhui; Zhou, Qin; Sun, Jiantong; Wang, Wenjuan; Ding, Xinyuan

Lu, Guangxian; Li, Jianhua; Ding, Leyun; Wang, Chenping; Tang, Lian; Liu, Xin; Xu, Jinhui; Zhou, Qin; Sun, Jiantong; Wang, Wenjuan; Ding, Xinyuan.

Afiliação

Lu G; Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Li J; Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
Ding L; Institute of Organ Transplantation, Fudan University, Shanghai, China.
Wang C; Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Tang L; Department of Pharmacy, Nantong Third Hospital Affiliated to Nantong University, Nantong, China.
Liu X; Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Xu J; Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Zhou Q; Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Sun J; Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Wang W; Department of Pharmacy, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.
Ding X; Department of Pharmacy, Children's Hospital of Soochow University, Soochow University, Suzhou, China.

Front Oncol ; 11: 629640, 2021.

Article em En | MEDLINE | ID: mdl-33718207

Palavras-chave

HER2+; UCHL1; breast cancer; chemoresistance; free fatty acid

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google